COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

bioRxiv posts many COVID19-related papers. A reminder: they have not been formally peer-reviewed and should not guide health-related behavior or be reported in the press as conclusive.

29,825 Articles (21,997 medRxiv, 7,828 bioRxiv)

Most recent first Previous |  Page 2822: Articles 28211-28220  | Next

Calcium channel blocker amlodipine besylate is associated with reduced case fatality rate of COVID-19 patients with hypertension
Zhang, L., Sun, Y., Zeng, H.-L., Peng, Y., Jiang, X., Shang, W.-J., Wu, Y., Li, S., Zhang, Y.-L., Yang, L., Chen, H., Jin, R., Liu, W., Li, H., Peng, K., Xiao, G.
10.1101/2020.04.08.20047134 — Posted: 2020-04-14 Discussion: Onsite
COVID-19: Recovering estimates of the infected fatality rate during an ongoing pandemic through partial data
Villa, M., Myers, J. F., Turkheimer, F.
10.1101/2020.04.10.20060764 — Posted: 2020-04-14
A Stratified Model to Quantify the Effects of Containment Policies on the Spread of COVID-19
Bokharaie, V. S.
10.1101/2020.04.10.20060681 — Posted: 2020-04-14
COVID-19 lockdowns cause global air pollution declines with implications for public health risk
Venter, Z. S., Aunan, K., Chowdhury, S., Lelieveld, J.
10.1101/2020.04.10.20060673 — Posted: 2020-04-14
Chaos, Percolation and the Coronavirus Spread: the Italian case
Bonasera, A., Bonasera, G., Zhang, S.
10.1101/2020.04.10.20060616 — Posted: 2020-04-14
Potency and timing of antiviral therapy as determinants of duration of SARS CoV-2 shedding and intensity of inflammatory response
Goyal, A., Cardozo-Ojeda, E. F., Schiffer, J. T.
10.1101/2020.04.10.20061325 — Posted: 2020-04-14 Discussion: Onsite
No evidence of clinical efficacy of hydroxychloroquine in patients hospitalized for COVID-19 infection with oxygen requirement: results of a study using routinely collected data to emulate a target trial
Mahevas, M., Tran, V.-T., Roumier, M., Chabrol, A., Paule, R., Guillaud, C., Gallien, S., Lepeule, R., Szwebel, T.-A., Lescure, X., Schlemmer, F., Matignon, M., Khellaf, M., Crickx, E., Terrier, B., Morbieu, C., Legendre, P., Dang, J., Schoindre, Y., Pawlotski, J.-M., Michel, M., Perrodeau, E., Carlier, N., Roche, N., De Lastours, V., Mouthon, L., Audureau, E., Ravaud, P., Godeau, B., Costedoat, N.
10.1101/2020.04.10.20060699 — Posted: 2020-04-14 Discussion: Onsite | Offsite
Protecting our health care workers while protecting our communities during the COVID-19 pandemic: a comparison of approaches and early outcomes in two Italian regions, Italy, 2020
Binkin, N., Salmaso, S., Michieletto, F., Russo, F.
10.1101/2020.04.10.20060707 — Posted: 2020-04-14
Risk Assessment of nCOVID-19 Pandemic In India: A Mathematical Model And Simulation
Biswas, S., Mukherjee, M.
10.1101/2020.04.10.20060830 — Posted: 2020-04-14
Impact of Social Vulnerability on COVID-19 Incidence and Outcomes in the United States
Nayak, A., Islam, S. J., Mehta, A., Ko, Y.-A., Patel, S. A., Goyal, A., Sullivan, S., Lewis, T. T., Vaccarino, V., Morris, A. A., Quyyumi, A. A.
10.1101/2020.04.10.20060962 — Posted: 2020-04-14

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).